Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...
Lineage Cell Therapeutics initiates DOSED clinical study of OPC1 for spinal cord injury: Carlsbad, California Thursday, February 13, 2025, 14:00 Hrs [IST] Lineage Cell Therapeutic ...
Sylvie Hudon was admitted to the hospital, she says nurses visiting her home told her not to worry about the bedsore located ...
Lineage Cell Therapeutics (LCTX) announced that the Company has initiated the DOSED clinical study. The DOSED study will evaluate the safety ...
UW Medicine is unveiling an FDA-approved spinal cord therapy in an effort to offer new hope for paralyzed patients.
A new FDA-approved device is bringing hope to people who have suffered spinal injuries and helping them regain function they ...
Spinal cord injury (SCI) remains the most serious complication of repairing descending thoracic and thoracoabdominal aortic aneurysms, with endovascular ...
Mission Viejo's neurosurgeon explores spinal cord stimulation as a promising alternative for chronic back pain relief, focusing on innovative treatments. MISSION VIEJO, CALIFORNIA / ACCESS Newswire / ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback